Vertex’s New Drug Tackles Cystic Fibrosis at Its Roots

A small clinical trial of an experimental drug made by Cambridge-based Vertex Pharmaceuticals has successfully targeted the root cause of cystic fibrosis, generating cautious excitement among doctors and patients.
boston